Endpoint-attached heparin blocks neutrophil sticking and spreading
Source abstract
Abstract
Neutrophils adhere to polymer surfaces by partly unknown mechanisms. Heparin-coating of such surfaces is employed to improve biocompatibility of extracorporeal circulation. The aim of the study was to investigate mechanisms for interactions between neutrophils and uncoated versus heparin-coated surfaces. Isolated human neutrophils were incubated in tissue culture plates. Uncoated plates induced sticking and spreading of unstimulated neutrophils. Heparin-coating reduced sticking by approximately 75%, and adherent cells were less spread (p<0.001). Experiments in plates coated with modified heparins showed that sticking and spreading were not related to anticoagulatory ability or surface charge. Unstimulated neutrophil sticking was unchanged whether the media contained divalent cations or 1mM ethylenediaminetetraacetic acid (EDTA). Spreading on uncoated plates was greater in the presence of Ca(2+) and/or Mg(2+) than with EDTA. Spreading of unstimulated neutrophils on heparin-coated plates varied little with different media. Pre-incubation with anti-CD11b/CD18 antibodies did not significantly influence adhesion to heparin-coated plates. There were no differences in expression of the antiadhesive receptor CD43 (leukosialin) on adherent neutrophils on uncoated and heparin-coated plates, and pre-incubation with anti-CD43 antibody had little effect on neutrophil sticking. These data indicate an adhesive mechanism independent of selectins, integrins, and leukosialin, and inhibition of sticking and spreading by heparin-coating.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Cell Adhesion Molecules Research · Platelet Disorders and Treatments · Proteoglycans and glycosaminoglycans research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (32)
Show source-provided references
1. Complement and the damaging effects of cardiopulmonary bypass10.1016/S0022-5223(19)39061-0 ↗
2. Reduced granulocyte activation with a heparin-coated device in an in vitro model of cardiopulmonary bypass10.1111/j.1525-1594.1991.tb00766.x ↗
3. Effects of heparin-coating of cardiopulmonary bypass circuits on leukocytes during simulated extracorporeal circulation10.1177/096721099700500604 ↗
4. Heparin is an adhesive ligand for the leukocyte integrin Mac-1 (CD11b/CD18)10.1083/jcb.130.6.1473 ↗
5. Heparin inhibits ligand binding to the leukocyte integrin Mac-110.1161/01.CIR.100.14.1533 ↗
6. The effects of heparin and related molecules upon the adhesion of human polymorphonuclear leucocytes to vascular endothelium in vitro10.1038/sj.bjp.0703099 ↗
7. Albumin inhibits neutrophil spreading and hydrogen peroxide release by blocking the shedding of CD43 (sialophorin, leukosialin)10.1083/jcb.122.1.243 ↗
8. Regional manifestation and control of the immune system10.1096/fj.01-0690hyp ↗
9. Functions of cell surface heparan sulfate proteoglycans10.1146/annurev.biochem.68.1.729 ↗
10. A new non-thrombogenic surface prepared by selective covalent binding of heparin via a modified reducing terminal residue10.3109/10731198309118804 ↗
11. Isolation of mononuclear cells and granulocytes from human blood
12. Shear-dependent inhibition of granulocyte adhesion to cultured endothelium by dextran sulfate10.1182/blood.V73.5.1324.1324 ↗
13. Assay method for myeloperoxidase in human polymorphonuclear leukocytes10.1016/0003-2697(83)90019-2 ↗
14. Heparin in clinical doses “primes” granulocytes to subsequent activation as measured by myeloperoxidase release10.1046/j.1365-3083.1996.d01-57.x ↗
15. Expression and regulation of adhesion molecules ICAM-1 (CD54) and LFA-3 (CD58) in human intestinal epithelial cell lines10.1111/j.1365-3083.1992.tb02973.x ↗
16. Conover WJ. Practical nonparametric statistics, 2nd ed. New York: Wiley; 1980. p. 229–37.
17. Cytokine-induced respiratory burst of human neutrophils10.1083/jcb.109.3.1341 ↗
18. Comparison of actin changes and calcium metabolism in plastic- and fibronectin-adherent human neutrophils10.4049/jimmunol.149.4.1388 ↗
19. A new in vitro model to study interaction with whole blood and biomaterials. Studies of platelets and coagulation activation and the effect of aspirin10.1016/S0142-9612(98)00210-5 ↗
20. Identification of heparin as a ligand for the A-domain of Plasmodium falciparum thrombospondin-related adhesion protein10.1016/S0166-6851(99)00052-3 ↗
21. Specific binding between human neutrophils and heparin10.1111/j.1365-2141.1992.tb08176.x ↗
22. Heparin attenuates TNF-α induced inflammatory response through a CD11b dependent mechanism10.1136/gut.47.1.88 ↗
23. Cytosolic free Ca2+ signals in single adherent human neutrophils10.1007/BF02072084 ↗
24. β2 integrins are not required for tyrosine phosphorylation of paxillin in human neutrophils10.4049/jimmunol.159.11.5568 ↗
25. CD43 (sialophorin, leukosialin) shedding is an initial event during neutrophil migration, which could be closely related to the spreading of adherent cells10.3109/15419069809040288 ↗
26. The role of proteoglycans in cell adhesion, migration and proliferation10.1016/0955-0674(92)90102-I ↗
27. In vitro leucocyte adhesion to modified polyurethane surfaces. I. Effect of ionizable functional groups10.1016/0142-9612(92)90114-4 ↗
28. Adhesion of leukocytes to endothelium10.1242/jcs.45.1.73 ↗
29. Biocompatibility of extracorporeal circulation10.1016/S0022-5223(19)36696-6 ↗
30. Reduced complement activation with heparin-coated oxygenator and tubings in coronary bypass operations10.1016/S0022-5223(19)34966-9 ↗
31. Heparin-coated cardiopulmonary bypass equipment. II. Mechanisms for reduced complement activation in vivo10.1016/S0022-5223(99)70302-8 ↗
32. Heparin coating reduces blood cell adhesion to arterial filters during coronary bypass10.1016/0003-4975(93)91106-W ↗